1. Home
  2. FNWB vs SERA Comparison

FNWB vs SERA Comparison

Compare FNWB & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.96

Market Cap

87.9M

Sector

Finance

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$3.59

Market Cap

90.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
SERA
Founded
1923
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.9M
90.6M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
FNWB
SERA
Price
$9.96
$3.59
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
31.1K
42.6K
Earning Date
01-28-2026
11-13-2025
Dividend Yield
1.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,052,000.00
$95,000.00
Revenue This Year
$31.86
$19.22
Revenue Next Year
$10.64
$400.00
P/E Ratio
N/A
N/A
Revenue Growth
6.47
1.06
52 Week Low
$6.05
$1.37
52 Week High
$12.10
$9.13

Technical Indicators

Market Signals
Indicator
FNWB
SERA
Relative Strength Index (RSI) 64.85 60.54
Support Level $9.80 $2.91
Resistance Level $10.14 $3.14
Average True Range (ATR) 0.21 0.26
MACD -0.04 0.04
Stochastic Oscillator 46.15 79.55

Price Performance

Historical Comparison
FNWB
SERA

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: